SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-21-049679
Filing Date
2021-09-24
Accepted
2021-09-24 07:31:18
Documents
104
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2021_inmedpharma.htm   iXBRL 10-K 1550093
2 AGREEMENT AND PLAN OF REORGANIZATION, DATED AS OF SEPTEMBER 10, 2021, BY AND AMO f10k2021ex2-1_inmedpharma.htm EX-2.1 717935
3 FORM OF SERIES A WARRANT (TO BE ISSUED PURSUANT TO THE AGREEMENT AND PLAN OF REO f10k2021ex4-6_inmedpharma.htm EX-4.6 80592
4 FORM OF SERIES B WARRANT (TO BE ISSUED PURSUANT TO THE AGREEMENT AND PLAN OF REO f10k2021ex4-7_inmedpharma.htm EX-4.7 79400
5 FORM OF INMED PHARMACEUTICALS INC. INDEMNIFICATION AGREEMENT ENTERED INTO WITH E f10k2021ex10-10_inmedpharma.htm EX-10.10 67666
6 SUBSIDIARIES OF INMED PHARMACEUTICALS INC f10k2021ex21-1_inmedpharma.htm EX-21.1 1035
7 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f10k2021ex23-1_inmedpharma.htm EX-23.1 2265
8 CERTIFICATION f10k2021ex31-1_inmedpharma.htm EX-31.1 10552
9 CERTIFICATION f10k2021ex31-2_inmedpharma.htm EX-31.2 10485
10 CERTIFICATION f10k2021ex32-1_inmedpharma.htm EX-32.1 2881
11 CERTIFICATION f10k2021ex32-2_inmedpharma.htm EX-32.2 2852
17 GRAPHIC image_001.jpg GRAPHIC 10706
18 GRAPHIC image_002.jpg GRAPHIC 24972
19 GRAPHIC image_003.jpg GRAPHIC 16628
20 GRAPHIC image_004.jpg GRAPHIC 21055
21 GRAPHIC image_005.jpg GRAPHIC 6337
22 GRAPHIC image_006.jpg GRAPHIC 24520
23 GRAPHIC image_007.jpg GRAPHIC 19962
24 GRAPHIC image_008.jpg GRAPHIC 17185
25 GRAPHIC image_009.jpg GRAPHIC 16423
26 GRAPHIC image_010.jpg GRAPHIC 15411
27 GRAPHIC image_011.jpg GRAPHIC 33338
28 GRAPHIC image_012.jpg GRAPHIC 13178
29 GRAPHIC image_013.jpg GRAPHIC 18922
30 GRAPHIC image_014.jpg GRAPHIC 34989
31 GRAPHIC image_015.jpg GRAPHIC 16423
32 GRAPHIC image_016.jpg GRAPHIC 14614
33 GRAPHIC image_017.jpg GRAPHIC 15324
34 GRAPHIC image_018.jpg GRAPHIC 24784
35 GRAPHIC image_019.jpg GRAPHIC 12870
36 GRAPHIC image_020.jpg GRAPHIC 14024
37 GRAPHIC image_021.jpg GRAPHIC 25317
38 GRAPHIC image_022.jpg GRAPHIC 27130
39 GRAPHIC image_023.jpg GRAPHIC 4237
  Complete submission text file 0001213900-21-049679.txt   7646707

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE inm-20210630.xsd EX-101.SCH 54799
13 XBRL CALCULATION FILE inm-20210630_cal.xml EX-101.CAL 25236
14 XBRL DEFINITION FILE inm-20210630_def.xml EX-101.DEF 213315
15 XBRL LABEL FILE inm-20210630_lab.xml EX-101.LAB 432894
16 XBRL PRESENTATION FILE inm-20210630_pre.xml EX-101.PRE 228173
40 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021_inmedpharma_htm.xml XML 529247
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-39685 | Film No.: 211274049
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences